Skip to main content
Premium Trial:

Request an Annual Quote

Eastern Biotech to Promote Decode Tests in Middle East

NEW YORK (GenomeWeb News) – Dubai, UAE-based Eastern Biotech said today that it has signed an agreement to promote Decode Genetics’ DNA-based tests for diabetes and other diseases in the Middle East.
 
The firm, which also runs a clinical reference lab, said that it would offer Decode’s tests for assessing risk of type 2 diabetes, myocardial infarction, atrial fibrillation, prostate cancer, glaucoma, breast cancer, and other tests currently under development by Decode.
 
Further terms of the alliance were not disclosed.